Belleville AMRAP Vapor Ranger Green Waterproof Tactical Boot

SKU: BV670WPT
$129.99

  • Made for street, range, and physical training duty use
  • Delivers lightweight cushioning and rebound for long wear
  • Expanded E-TPU midsole offers superior resiliency versus EVA
  • Waterproof textile upper with bloodborne pathogen proof membrane
Selected Color is
Ships from the Manufacturer - No PO Boxes - Allow 1-2 Business Days For Processing
Adding to cart… The item has been added

Trusted for 25 Years

Price Match Guarantee

The Belleville AMRAP Vapor Tactical Boot features a proprietary expanded TPU midsole that provides superior resiliency and rebound (up to 50% more than standard EVA) and is ideal for a lightweight "sneaker-boot" option for street use, range use, and physical training. The AMRAP Vapor also has a waterproof/bloodborne pathogen proof textile upper.

Features:

  • Height: Mid-Cut
  • Upper: 100% Textile
  • Midsole: Expanded TPU
  • Outsole: 100% Rubber
  • Insole: Removable Molded-EVA
  • High Resiliency And Rebound E-TPU Midsole
  • Waterproof & Bloodborne Pathogen Proof Membrane
  • Athletic-Style "Ghilly" Lacing System
  • Athletic Strobel Construction

WARNING: This product can expose you to chemicals including arsenic, which is known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.

Overall rating: 4.0 / 5 from 2 reviews.

AI Generated Review Summary

Summary topics

Review topics: [].

Review highlights

Reviews

would buy again

"great"

— MICHAEL G. (5/5)

Don’t Know Yet

"Got them in. First look was the seams where they are glued aren’t really clean. Preference thing. I have Salomon speed assaults wear everyday. (Don’t stand close) They seem a little big I wear size 12 and could prob wear 11.5. Sole feels like it could be comfortable and definitely cushion but not over so that it feels unstable. No logos or anything so kinda appears cheap. Doesn’t seem like they would be hard to break in as they’re not hurting feet or around ankle."

— Captain (3/5)

Q&A